National MS Society, Teva release report on trends in MS care
NEW YORK The National Multiple Sclerosis Society and Teva Neuroscience have joined together to conduct a study entitled Multiple Sclerosis Trend Report: Perspectives from Managed Care, Providers, and Patients.
The study evaluated MS views and experiences with managed care professionals, individuals living with the disease and health care professionals. The results showed that people living with the disease could manage it better with greater collaboration and more efficient disease management among neurologists, managed care organizations and specialty pharmacies.
Study results showed:
- Significant obstacles exist in optimal disease management, early treatment and patient adherence to that treatment, which are essential in helping slowing the progression of MS and managing symptoms.
- Specialty pharmacies are playing an increasingly important role in coordinated care for individuals living with MS. In fact, 95 percent of all specialty pharmacy respondents stated that they believe can enhance how health care professionals deliver care to MS patients.
- Neurologists are feeling so overwhelmed by the administrative barriers to diagnosing and treating MS that 64 percent say they would prefer not to take on more MS patients.
- Diagnosing MS earlier, starting treatment sooner, ensuring compliance and adherence to treatment, and better management of the disease could reduce long-term costs for managed care organizations.
The study calls for a uniform collaboration by all parties involved to help with the management of MS.
Parata launches PACMED C30 packaging technology
DURHAM, N.C. Parata Systems has launched its new product, the PACMED C30, which is a packaging technology used to extend the safety and convenience of its onePAC packaging system.
onePac is a strip that contains information like patients’ medications, patient names, pill descriptions and time of day to take a dose of the medication. On the strip, up to 19 lines of information can be held. The goal of the strips are to remind patients who take multiple medications when to take what medications and how much of each medication.
The PACMED C30 expands on the technology of the onePAC by combining multiple onePAC strips together for easy access by patients. PACMED C30 is efficient and accurate, generating up to 60 unit-dose or 50 multi-dose packages a minute.
“Adherence is a critical touch point in the circle of pharmacy care, and Parata’s launch of PACMED C30 offers an exciting new way for pharmacies to extend their care by improving patient adherence, safety and convenience,” says Tom Rhoads, executive vice president for customer and market strategies at Parata Systems.
Teva announces availablility of generic Fosamax
NORTH WALES, Pa. Teva has announced the introduction and availability of alendronate sodium tablets.
This is the generic version of the osteoporosis drug Fosamax by Merck. The drug will be available in 5 mg, 10 mg, 35 mg, 40 mg and 70 mg strengths.
“Our customers count on Teva for a continuous supply of new generic products,” stated John Denman, vice president of sales and marketing. “With the launch of alendronate sodium tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”